First-mover advantage and the private value of public science

A Arora, S Belenzon, B Dionisi - Research Policy, 2023 - Elsevier
Technical progress increasingly relies on the use of scientific knowledge. But if much of this
knowledge is in the public domain, can it be a source of private value? We find that average …

Exploring SureChEMBL from a drug discovery perspective

Y Gadiya, S Shetty, M Hofmann-Apitius, P Gribbon… - Scientific Data, 2024 - nature.com
In the pharmaceutical industry, the patent protection of drugs and medicines is accorded
importance because of the high costs involved in the development of novel drugs. Over the …

Medicinal chemistry lens on patent data in SureChEMBL

Y Gadiya, S Shetty, M Hofmann-Apitius, P Gribbon… - bioRxiv, 2023 - biorxiv.org
In the pharmaceutical industry, the patent protection of drugs and medicines is accorded
particular importance because of the high costs of research and development (R&D) …

Essays on the Direction of Technical Change

B Dionisi - 2023 - search.proquest.com
The rate and direction of inventive activity are central to firms' competitiveness as well as
economic growth. A fundamental question arises from the fact that innovation increasingly …